First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

Clinical trial NCT06795022 · RECRUITING

Trial details

NCT number: NCT06795022
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2025-03-27
Primary completion: 2027-06-30
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.